Argos sets IPO range

Argos Therapeutics Inc. (Durham, N.C.) amended its IPO and now plans to sell 5.3 million shares at $13-$15 per share. A $14 price would raise $73.5 million and value the company at $215.2 million. Lazard; Canaccord; BMO Capital Markets; and Needham are underwriters. Last July, Argos filed to raise up to $86.3 million. ...